Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 19 studies | 44% ± 18% | |
lung | 17 studies | 28% ± 12% | |
eye | 11 studies | 48% ± 19% | |
peripheral blood | 8 studies | 32% ± 15% | |
heart | 5 studies | 27% ± 7% | |
liver | 5 studies | 31% ± 16% | |
intestine | 5 studies | 22% ± 7% | |
kidney | 4 studies | 23% ± 6% | |
bone marrow | 4 studies | 38% ± 23% | |
adipose | 4 studies | 35% ± 16% | |
pancreas | 3 studies | 56% ± 23% | |
placenta | 3 studies | 31% ± 16% | |
uterus | 3 studies | 32% ± 15% | |
breast | 3 studies | 20% ± 5% | |
skin | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 29283.40 | 2642 / 2642 | 100% | 290.33 | 705 / 705 |
esophagus | 100% | 16039.12 | 1445 / 1445 | 100% | 200.26 | 183 / 183 |
intestine | 100% | 18219.34 | 966 / 966 | 100% | 190.94 | 527 / 527 |
ovary | 100% | 14850.35 | 180 / 180 | 100% | 190.42 | 430 / 430 |
prostate | 100% | 14969.14 | 245 / 245 | 100% | 225.48 | 502 / 502 |
stomach | 100% | 11962.57 | 359 / 359 | 100% | 185.80 | 286 / 286 |
uterus | 100% | 18047.73 | 170 / 170 | 100% | 201.68 | 459 / 459 |
skin | 100% | 19706.49 | 1808 / 1809 | 100% | 261.55 | 472 / 472 |
lung | 100% | 20656.69 | 578 / 578 | 100% | 212.22 | 1154 / 1155 |
thymus | 100% | 14579.85 | 652 / 653 | 100% | 185.37 | 604 / 605 |
kidney | 100% | 15534.87 | 89 / 89 | 100% | 188.39 | 898 / 901 |
breast | 100% | 18625.59 | 459 / 459 | 100% | 253.00 | 1114 / 1118 |
bladder | 100% | 18702.24 | 21 / 21 | 100% | 199.63 | 502 / 504 |
liver | 98% | 6834.03 | 222 / 226 | 99% | 95.96 | 400 / 406 |
adrenal gland | 100% | 15987.33 | 258 / 258 | 96% | 154.97 | 221 / 230 |
pancreas | 96% | 6406.25 | 315 / 328 | 99% | 200.28 | 177 / 178 |
adipose | 100% | 20388.24 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 23153.63 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 194.98 | 29 / 29 |
spleen | 100% | 16205.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 196.69 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 131.80 | 1 / 1 |
heart | 99% | 9638.34 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 18800.58 | 921 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 141.35 | 79 / 80 |
muscle | 77% | 3725.32 | 617 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071380 | Biological process | cellular response to prostaglandin E stimulus |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0008283 | Biological process | cell population proliferation |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0007213 | Biological process | G protein-coupled acetylcholine receptor signaling pathway |
GO_0007165 | Biological process | signal transduction |
GO_0007191 | Biological process | adenylate cyclase-activating dopamine receptor signaling pathway |
GO_0060041 | Biological process | retina development in camera-type eye |
GO_0050909 | Biological process | sensory perception of taste |
GO_0071870 | Biological process | cellular response to catecholamine stimulus |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_1903561 | Cellular component | extracellular vesicle |
GO_0097381 | Cellular component | photoreceptor disc membrane |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005834 | Cellular component | heterotrimeric G-protein complex |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0051020 | Molecular function | GTPase binding |
GO_0030159 | Molecular function | signaling receptor complex adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | GNB1 |
Protein name | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1) G protein subunit beta 1 (cDNA FLJ16663 fis, clone THYMU2005759, highly similar to Guanine nucleotide-binding proteinG(I)/G(S)/G(T) subunit beta 1) Alternative protein GNB1 |
Synonyms | |
Description | FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. . FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. . FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. . FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. . FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. . FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. . |
Accessions | ENST00000703694.1 [P62873-1] F6X3N5 ENST00000703702.1 [P62873-1] ENST00000703711.1 [P62873-1] P62873 ENST00000703701.1 [P62873-1] ENST00000703692.1 [P62873-1] F6UT28 ENST00000378609.9 [P62873-1] ENST00000703700.1 [P62873-1] ENST00000437146.1 B3KVK2 ENST00000703699.1 [P62873-1] ENST00000703708.1 [P62873-1] ENST00000703704.1 [P62873-1] L8E8V9 A0A994J6X8 B1AKQ8 ENST00000615252.5 ENST00000703693.1 [P62873-1] ENST00000610897.4 [P62873-1] ENST00000434686.6 ENST00000703696.1 [P62873-1] ENST00000703697.1 [P62873-1] ENST00000703705.1 ENST00000703709.1 [P62873-1] ENST00000703707.1 ENST00000703706.1 [P62873-1] A0A994J3T6 ENST00000703703.1 [P62873-1] ENST00000703710.1 [P62873-1] A0A2L0WW42 ENST00000703695.1 ENST00000439272.7 |